![Henric Bjarke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henric Bjarke
Directeur Général chez
Tenpoint Therapeutics Ltd.
Profil
Henric Bjarke is currently the Chief Executive Officer at Visus Therapeutics, Inc. and the Chief Executive Officer & Director at Tenpoint Therapeutics Ltd. He previously worked as a Senior Director at Oldtech, Inc., Vice President-Marketing at Actavis, Inc., VP-Global Metabolic Disorders Franchise at Alexion Pharmaceuticals, Inc., Specialty Sales Representative at Pharmacia AB, Chief Commercial Officer & Senior Vice President at IVERIC bio, Inc., Principal at Direct Enterprise, Inc., and Chief Operating Officer & Senior Vice President at Inozyme Pharma, Inc. Mr. Bjarke completed his undergraduate degree at the University of Uppsala.
Postes actifs de Henric Bjarke
| Sociétés | Poste | Début |
|---|---|---|
Tenpoint Therapeutics Ltd.
 Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company developing treatments to rejuvenate vision in the aging eye | Directeur Général | 01/10/2024 |
Visus Therapeutics, Inc.
 Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops ophthalmic therapeutic medicines | Directeur Général | - |
Anciens postes connus de Henric Bjarke
| Sociétés | Poste | Fin |
|---|---|---|
| INOZYME PHARMA, INC. | Directeur des opérations | 31/12/2022 |
| IVERIC BIO, INC. | Corporate Officer/Principal | 17/03/2017 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2015 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Sales & Marketing | - |
Pharmacia AB
 Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | - |
Formation de Henric Bjarke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
Direct Enterprise, Inc.
 Direct Enterprise, Inc. Medical SpecialtiesHealth Technology Provides drug screening test equipment and related services | Health Technology |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops ophthalmic therapeutic medicines | Health Technology |
Tenpoint Therapeutics Ltd.
Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company developing treatments to rejuvenate vision in the aging eye | Health Technology |
